<?xml version="1.0" encoding="UTF-8"?>
<record
    xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
    xsi:schemaLocation="http://www.loc.gov/MARC21/slim http://www.loc.gov/standards/marcxml/schema/MARC21slim.xsd"
    xmlns="http://www.loc.gov/MARC21/slim">

  <leader>     nam a22     7a 4500</leader>
  <datafield tag="999" ind1=" " ind2=" ">
    <subfield code="c">7857</subfield>
    <subfield code="d">7857</subfield>
  </datafield>
  <controlfield tag="003">IQ-NaUA</controlfield>
  <controlfield tag="005">20221101064410.0</controlfield>
  <controlfield tag="008">110512s2012    nyu      b    001 0 eng  </controlfield>
  <datafield tag="020" ind1=" " ind2=" ">
    <subfield code="a">9780071603935 (hardcover : alk. paper)</subfield>
  </datafield>
  <datafield tag="020" ind1=" " ind2=" ">
    <subfield code="a"> 007160393X (hardcover : alk. paper)</subfield>
  </datafield>
  <datafield tag="040" ind1=" " ind2=" ">
    <subfield code="a">IQ-NaUA</subfield>
    <subfield code="b">ara</subfield>
    <subfield code="c">IQ-NaUA</subfield>
    <subfield code="d">IQ-KaLSS</subfield>
    <subfield code="e">rda</subfield>
  </datafield>
  <datafield tag="050" ind1=" " ind2="4">
    <subfield code="a"> RM301.4</subfield>
    <subfield code="b">.S52 2012</subfield>
  </datafield>
  <datafield tag="100" ind1="1" ind2=" ">
    <subfield code="a">Shargel, Leon, </subfield>
    <subfield code="d"> 1941-</subfield>
    <subfield code="e">author. </subfield>
  </datafield>
  <datafield tag="245" ind1="1" ind2="0">
    <subfield code="a">Applied biopharmaceutics &amp; pharmacokinetics / </subfield>
    <subfield code="b"> Leon Shargel, Andrew B.C. Yu, Susanna Wu-Pong.</subfield>
  </datafield>
  <datafield tag="246" ind1="1" ind2=" ">
    <subfield code="a"> Applied biopharmaceutics and pharmacokinetics</subfield>
  </datafield>
  <datafield tag="250" ind1=" " ind2=" ">
    <subfield code="a">6th ed.</subfield>
  </datafield>
  <datafield tag="260" ind1=" " ind2=" ">
    <subfield code="a"> </subfield>
  </datafield>
  <datafield tag="264" ind1=" " ind2="1">
    <subfield code="a">New York : </subfield>
    <subfield code="b">McGraw-Hill, </subfield>
    <subfield code="c">2012 c. </subfield>
  </datafield>
  <datafield tag="300" ind1=" " ind2=" ">
    <subfield code="a"> 782 p ;</subfield>
    <subfield code="c">25 cm. </subfield>
  </datafield>
  <datafield tag="336" ind1=" " ind2=" ">
    <subfield code="2">rdacontent</subfield>
    <subfield code="a">&#x646;&#x635;</subfield>
    <subfield code="b">txt</subfield>
  </datafield>
  <datafield tag="337" ind1=" " ind2=" ">
    <subfield code="2">rdamedia</subfield>
    <subfield code="a">&#x62F;&#x648;&#x646; &#x648;&#x633;&#x64A;&#x637;</subfield>
    <subfield code="b">n</subfield>
  </datafield>
  <datafield tag="338" ind1=" " ind2=" ">
    <subfield code="2">rdacarrier</subfield>
    <subfield code="a">&#x645;&#x62C;&#x644;&#x62F;</subfield>
    <subfield code="b">nc</subfield>
  </datafield>
  <datafield tag="504" ind1=" " ind2=" ">
    <subfield code="a">Includes bibliographical references and index.</subfield>
  </datafield>
  <datafield tag="505" ind1="0" ind2=" ">
    <subfield code="a">	 |a Introduction to biopharmaceutics and pharmacokinetics -- Mathematic fundamentals in pharmacokinetics -- One-compartment open model: intravenous bolus administration -- Multicompartmental models : intravenous bolus administration -- Intravenous infusion -- Drug elimination and clearance -- Pharmacokinetics of oral absorption -- Multiple-dosage regimens -- Nonlinear pharmacokinetics -- Physiologic drug distribution and protein binding -- Drug elimination and hepatic clearance -- Pharmacogenetics -- Physiologic factors related to drug absorption -- Biopharmaceutic considerations in drug product design and in vitro drug product performance -- Drug product performance, in vivo : bioavailability and bioequivalence -- Impact of drug product quality and biopharmaceutics on clinical efficacy -- Modified-release drug products -- Targeted drug delivery systems and biotechnology products -- Relationship between pharmacokinetics and pharmacodynamics -- Application of pharmacokinetics to clinical situations -- Dosage adjustment in renal and hepatic disease.</subfield>
  </datafield>
  <datafield tag="650" ind1=" " ind2="4">
    <subfield code="a">Biopharmaceutics.</subfield>
  </datafield>
  <datafield tag="650" ind1=" " ind2="4">
    <subfield code="a"> Pharmacokinetics.</subfield>
  </datafield>
  <datafield tag="650" ind1=" " ind2="4">
    <subfield code="a">Biopharmaceutics.</subfield>
  </datafield>
  <datafield tag="650" ind1=" " ind2="4">
    <subfield code="a">Models, Chemical.</subfield>
  </datafield>
  <datafield tag="650" ind1=" " ind2="4">
    <subfield code="a"> Pharmacokinetics.</subfield>
  </datafield>
  <datafield tag="700" ind1="1" ind2=" ">
    <subfield code="a"> Yu, Andrew B. C.,</subfield>
    <subfield code="d">1945- </subfield>
  </datafield>
  <datafield tag="700" ind1="1" ind2=" ">
    <subfield code="a">Wu-Pong, Susanna.</subfield>
  </datafield>
  <datafield tag="910" ind1=" " ind2=" ">
    <subfield code="a">&#x633;&#x627;&#x631;&#x629; &#x62D;&#x645;&#x64A;&#x62F; &#x627;&#x644;&#x645;&#x631;&#x634;&#x62F;&#x64A;. </subfield>
  </datafield>
  <datafield tag="942" ind1=" " ind2=" ">
    <subfield code="2">lcc</subfield>
    <subfield code="c">BK</subfield>
  </datafield>
</record>
